Holen Sie sich die Stockscreener-App
7.80
1.76%
-0.14
Handel nachbörslich:
7.73
-0.07
-0.90%
Schlusskurs vom Vortag:
$7.94
Offen:
$7.89
24-Stunden-Volumen:
35,665
Relative Volume:
0.41
Marktkapitalisierung:
$296.86M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-4.6451
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-1.64%
1M Leistung:
+1.17%
6M Leistung:
-24.93%
1J Leistung:
-14.10%
1-Tages-Spanne:
$7.66
$7.89
1-Wochen-Bereich:
$7.66
$8.37
52-Wochen-Spanne:
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
7.80 | 296.86M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
What analysts say about Nyxoah SA stockOutperformance with explosive growth - jammulinksnews.com
Nyxoah SA Stock Analysis and ForecastTremendous gains - jammulinksnews.com
What drives Nyxoah SA stock priceFree Trading Psychology Coaching - jammulinksnews.com
Is Nyxoah SA a good long term investmentHigh-yield portfolio picks - jammulinksnews.com
Trend Tracker for (NYXH) - news.stocktradersdaily.com
Nyxoah’s Innovative Approach to Sleep Apnea: A Clinical Study Update - TipRanks
Is Nyxoah SA stock a growth or value playControlled Risk High Reward Plan - Newser
What makes Nyxoah SA stock price move sharplyShort Squeeze Radar - Newser
Why Nyxoah SA stock attracts strong analyst attentionFree Access to Investment Community - Newser
How Nyxoah SA stock performs during market volatilitySmart High Yield Swing Trades - Newser
Nyxoah SA Announces New Share Issuance to Strengthen Financial Structure - TipRanks
Nyxoah's Sleep Apnea Device Awaits FDA NodDon't Sleep On This Stock - RTTNews
(NYXH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025 - yahoo.co
Major Governance Shift: Nyxoah Grants Long-term Shareholders New Board Nomination Rights - Stock Titan
Cantor Fitzgerald Forecasts Nyxoah FY2026 Earnings - Defense World
Ameriprise Financial Inc. Takes $135,000 Position in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
When the Price of (NYXH) Talks, People Listen - news.stocktradersdaily.com
Top Premarket Decliners - marketscreener.com
Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Nyxoah Announces Change in Shareholder Voting Rights - TipRanks
Vestal Point Capital Cuts Nyxoah Holdings by 40%: Major Ownership Shift Revealed - Stock Titan
Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times
Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan
Nyxoah SA Updates Share Capital and Voting Rights - TipRanks
Information on the total number of voting rights and shares - Yahoo
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World
Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria
Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com
Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN
Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):